JPMorgan Chase & Co’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.2K | Sell |
16,675
-815,592
| -98% | -$1.43M | ﹤0.01% | 5244 |
|
|
2025
Q1 | $1.46M | Sell |
832,267
-105,641
| -11% | -$185K | ﹤0.01% | 3446 |
|
|
2024
Q4 | $1.61M | Buy |
937,908
+874,842
| +1,387% | +$1.5M | ﹤0.01% | 3527 |
|
|
2024
Q3 | $156K | Buy |
63,066
+45,189
| +253% | +$112K | ﹤0.01% | 4558 |
|
|
2024
Q2 | $60.1K | Sell |
17,877
-54,013
| -75% | -$181K | ﹤0.01% | 4833 |
|
|
2024
Q1 | $291K | Buy |
71,890
+37,945
| +112% | +$154K | ﹤0.01% | 4247 |
|
|
2023
Q4 | $130K | Buy |
33,945
+22,920
| +208% | +$88K | ﹤0.01% | 4655 |
|
|
2023
Q3 | $46K | Buy |
11,025
+9,750
| +765% | +$40.7K | ﹤0.01% | 4937 |
|
|
2023
Q2 | $6.13K | Buy |
1,275
+38
| +3% | +$183 | ﹤0.01% | 5244 |
|
|
2023
Q1 | $5K | Buy |
1,237
+108
| +10% | +$437 | ﹤0.01% | 5374 |
|
|
2022
Q4 | $6K | Sell |
1,129
-1,298
| -53% | -$6.9K | ﹤0.01% | 5175 |
|
|
2022
Q3 | $24K | Buy |
2,427
+805
| +50% | +$7.96K | ﹤0.01% | 4879 |
|
|
2022
Q2 | $8K | Sell |
1,622
-16,427
| -91% | -$81K | ﹤0.01% | 5212 |
|
|
2022
Q1 | $71K | Buy |
18,049
+10,809
| +149% | +$42.5K | ﹤0.01% | 4875 |
|
|
2021
Q4 | $49K | Buy |
7,240
+3,568
| +97% | +$24.1K | ﹤0.01% | 5080 |
|
|
2021
Q3 | $55K | Buy |
+3,672
| New | +$55K | ﹤0.01% | 4928 |
|